This ticker has not been starred yet CRDF Cardiff Oncology, Inc.
Biological Products (no Diagnostic Substances)
Book value per $ invested $ 0.50
Leverage 22.62%
Market Cap $ 117.9m
PE 0.00
Dividend Yield 0.00%
Profit $ -50.9m
Margin -9212.87%

Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer. The company is headquartered in San Diego, California.

Subscribe Now For Access - Only $1.99 Per Month